Dilan Patel, a women's health coach said he was living his life as any other young adult when he started experiencing night sweats - and then he was diagnosed with cancer

Colon cancer remains one of the most prevalent yet often undetected forms of cancer, developing silently in the large intestine. According to recent medical

Popular weight loss injections including Ozempic, Wegovy and Mounjaro could increase the risk of thyroid cancer within the first year of use, concerning new research has suggested. The drugs, which have helped millions of people shed up to a fifth of their body weight,

Speaking to Express.co.uk, Doctor Robin Clark - medical director at Bupa Health Insurance - warned that patients with bowel cancer might experience anaemia. This is because the person could be bleeding internally, and more specifically, bleeding from the tumour.

Dr. Anna Arthur discusses how the NOURISH trial is addressing food insecurity and malnutrition in patients undergoing treatment for their blood cancers.

Ozempic and Wegovy do the same thing as GLP-1 would normally do for you — but to enable them to treat diabetes and obesity, not just the glucose impact of individual meals, they’ve been designed, largely thanks to Knudsen’s work, with slight changes to allow them to hang out in the blood longer than GLP-1 normally does.

Doctors say new research has found a link between weight-loss drugs and cancer, putting users at 'significantly higher risk' of the disease. The injections were originally made to tackle diabetes and research in the USA has found they come with a greater risk of cancer than other diabetes drugs.

Barry Stein had ignored symptoms that started appearing in 1995, until he was diagnosed with stage four colorectal cancer.

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the risks of substance abuse disorders, psychosis, infections, some kinds of cancer and dementia,

Navjot Singh Sidhu stuns fans with his jaw-dropping 33 kg weight loss in just five months! Discover his fitness secrets diet plan and why staying fit after 60 is crucial

Amycretin, a novel once-weekly subcutaneous GLP-1 and amylin receptor agonist, was safe compared with other incretin-based therapies and lead to significant weight loss in adults, according to top-line results from a phase 1b/2a trial.

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.